The observations that hepcidin deficiency and renal iron overload are associated with a lower systolic blood pressure supports our ongoing hypothesis that hepcidin-induced chronic anemia of inflammation may contribute to hypertension by dysregulating ENaC activity and renal sodium retention. Here, HAMP is linked to hypertensive disorder.